DoW Ovarian Cancer, Clinical Trial Award

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

• NAICS12.420

• HT942526OCRPCTA_GG.pdf

  application/pdf699 KB
  Download
• FY26 OCRP PA Reference Table _Final.pdf

  application/pdf177 KB
  Download

• Danielle Reckley Grantor
  help@ebrap.org301-619-1139